From inhibition of radiographic progression to maintaining structural integrity: A methodological framework for radiographic progression in rheumatoid arthritis and psoriatic arthritis clinical trials

Annals of the Rheumatic Diseases

Volumn 72, Issue 7, 2013, Pages 1113-1117

  Landewé, Robert ^a   Strand, Vibeke ^b   Van Der Heijde, Désirée ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

BIOASSAY; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DRUG EFFICACY; HUMAN; HYPOTHESIS; JOINT RADIOGRAPHY; JOINT SPACE NARROWING; MEASUREMENT ERROR; MUSCULOSKELETAL SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PSORIATIC ARTHRITIS; RADIOGRAPHIC PROGRESSION INHIBITION; RADIOLOGICAL PARAMETERS; RHEUMATOID ARTHRITIS; SHORT SURVEY;

DMARDS (BIOLOGIC); PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; TREATMENT;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84878412475     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-203159     Document Type: Short Survey

References (9)

1. Rahman MU, Buchanan J, Doyle MK, et al. Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years. Ann Rheum Dis 2011;70:1631-40.
2. van der Heijde D, Simon L, Smolen J, et al. How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. Arthritis Rheum 2002;47:215-18. (Pubitemid 34303850)
3. Lukas C, van der Heijde D, Fatenajad S, et al. Repair of erosions occurs almost exclusively in damaged joints without swelling. Ann Rheum Dis 2010;69:851-5.
4. Landewé R, van der Heijde D. Radiographic progression depicted by probability plots: presenting data with optimal use of individual values. Arthritis Rheum 2004;50:699-706. (Pubitemid 38326167)
5. Østergaard M, Peterfy C, Conaghan P, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003;30:1385-6. (Pubitemid 36666373)
6. Bøyesen P, McQueen FM, Gandjbakhch F, et al. The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop. J Rheumatol 2011;38:2034-8.
7. Conaghan PG, McQueen FM, Bird P, et al. Update on research and future directions of the OMERACT MRI inflammatory arthritis group. J Rheumatol 2011;38:2031-3.
8. Landewé R, van der Heijde D, Klareskog L, et al. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006;54:3119-25. (Pubitemid 44622081)
9. Fries JF, Bloch DA, Sharp JT, et al. Assessment of radiologic progression in rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum 1986;29:1-9. (Pubitemid 17015400)